Ticker brief

GKOS

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
8
authors 14d
8

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-06-25 → 2026-07-02 · now +0.12 (−1 bearish … +1 bullish)
Who spoke8
authorgradetrader scoresignalsmean sent
@BioStocksC-0.391+0.15
@OzmosiHealthC·1+0.20
@BiopharmIQB·1+0.15
@fj_nextstageC+1.071-0.05
@JaguarAnalyticsB+0.011+0.50
@EmmanuelInvestC-1.121+0.40
@finviz_comC·1+0.25
@AlexMarenco1C+0.751+0.00
Recent signals8of 8 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-07-02@AlexMarenco1+0.00Market recap cites Nasdaq below 50DMA, Dow new high, distribution days, and exposure level.·
2026-07-02@finviz_com+0.25Finviz reports 228 large-cap stocks hit 52-week highs and lists top movers.·
2026-07-01@EmmanuelInvest+0.40Piper Sandler reiterates GKOS Overweight with $165 PT.·
2026-06-28@JaguarAnalytics+0.50Ophthalmologist interview suggests pent-up demand for Epioxa at launch.·
2026-06-25@fj_nextstage-0.05IBD50 additions/removals with author skeptical of volatile additions.·
2026-06-25@BiopharmIQ+0.15Biotech open news list with price moves and company catalysts, capped to six tickers.·
2026-06-25@OzmosiHealth+0.20Glaukos completes patient enrollment in Phase 2 GLK-321 study.·
2026-06-25@BioStocks+0.15Multiple biopharma enrollment and dosing updates with expected topline timing.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.